A reduction in topotecan clearance was observed however there are insufficient data available to make a dose recommendation for this patient group.
Täheldati topotekaani kliirensi vähenemist, samas ei ole küllaldaselt andmeid, et anda soovitusi selle patsiendigrupi jaoks.